Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

Andrew P. Hearn; Oliver D. Hug; Ziana A. Somani; Joanne Kavanagh; Grainne d'Ancona; Cris Roxas; Linda Green; Louise Thomson; Mariana Fernandes; Brian D. Kent; Jaideep Dhariwal; Alexandra M. Nanzer; David J. Jackson

doi:10.1183/13993003.00166-2021

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

Andrew P. Hearn, Oliver D. Hug, Ziana A. Somani, Joanne Kavanagh, Grainne d'Ancona, Cris Roxas, Linda Green, Louise Thomson, Mariana Fernandes, Brian D. Kent, Jaideep Dhariwal, Alexandra M. Nanzer, David J. Jackson

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Article number	2100166
Journal	The European respiratory journal
Volume	57
Issue number	6
DOIs	https://doi.org/10.1183/13993003.00166-2021
Publication status	Published - 1 Jun 2021

Access to Document

10.1183/13993003.00166-2021

Cite this

Hearn, A. P., Hug, O. D., Somani, Z. A., Kavanagh, J., d'Ancona, G., Roxas, C., Green, L., Thomson, L., Fernandes, M., Kent, B. D., Dhariwal, J., Nanzer, A. M., & Jackson, D. J. (2021). Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy. The European respiratory journal, 57(6), Article 2100166. https://doi.org/10.1183/13993003.00166-2021

@article{39687d5f097c4b3f8e4268cbe1f5d313,

title = "Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy",

author = "Hearn, {Andrew P.} and Hug, {Oliver D.} and Somani, {Ziana A.} and Joanne Kavanagh and Grainne d'Ancona and Cris Roxas and Linda Green and Louise Thomson and Mariana Fernandes and Kent, {Brian D.} and Jaideep Dhariwal and Nanzer, {Alexandra M.} and Jackson, {David J.}",

year = "2021",

month = jun,

day = "1",

doi = "10.1183/13993003.00166-2021",

language = "English",

volume = "57",

journal = "The European respiratory journal",

issn = "1399-3003",

publisher = "European Respiratory Society",

number = "6",

}

TY - JOUR

T1 - Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

AU - Hearn, Andrew P.

AU - Hug, Oliver D.

AU - Somani, Ziana A.

AU - Kavanagh, Joanne

AU - d'Ancona, Grainne

AU - Roxas, Cris

AU - Green, Linda

AU - Thomson, Louise

AU - Fernandes, Mariana

AU - Kent, Brian D.

AU - Dhariwal, Jaideep

AU - Nanzer, Alexandra M.

AU - Jackson, David J.

PY - 2021/6/1

Y1 - 2021/6/1

UR - http://www.scopus.com/inward/record.url?scp=85108123702&partnerID=8YFLogxK

U2 - 10.1183/13993003.00166-2021

DO - 10.1183/13993003.00166-2021

M3 - Letter

C2 - 33632798

AN - SCOPUS:85108123702

SN - 1399-3003

VL - 57

JO - The European respiratory journal

JF - The European respiratory journal

IS - 6

M1 - 2100166

ER -

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

Access to Document

Other files and links

Cite this